Stem Cell-Derived Exosomes as a Therapeutic Option for Spinal Cord In-juries; a Systematic Review and Meta-Analysis
Open Access
- 1 January 2025
- journal article
- review article
- Vol. 13 (1) , e2
Abstract
Introduction: Exosomes function as cell signaling carriers and have drawn much attention to the cell-free treatments of regenerative medicine. This meta-analysis aimed to investigate the efficacy of mesenchymal stem cell-derived (MSCderived) exosomes in animal models of spinal cord injuries (SCI). Methods: A comprehensive search was conducted in Medline, Embase, Scopus, and Web of Science to attain related articles published by January 31, 2023. The eligible keywords were correlated with the spinal cord injury and MSC-derived exosomes. The evaluated outcomes were locomotion, cavity size, cell apoptosis, inflammation, neuro-regeneration, and microglia activation. A standardized mean difference was calculated for each sample and a pooled effect size was reported. Results: 65 papers fully met the inclusion criteria. Treatment with MSC-derived exosomes ultimately improved locomotion and shrunk cavity size (p<0.0001). The administration of MSC-derived exosomes enhanced the expression of beta-tubulin III, NF200, and GAP-43, and increased the number of NeuN-positive and Nissl-positive cells, while reducing the expression of glial fibrillary acidic protein (p<0.0001). The number of apoptotic cells in the treatment group decreased significantly (p<0.0001). Regarding the markers of microglia activation, MSC-derived exosomes increased the number of CD206- and CD68-positive cells (p=0.032 and p<0.0001, respectively). Additionally, MSC-derived exosome administration significantly increased the expression of the anti-inflammatory interleukin (IL)-10 and IL-4 (p<0.001 and p=0.001, respectively) and decreased the expression of the inflammatory IL-1b, IL-6, and TNF-a (p<0.0001). Conclusions: MSC-derived exosome treatment resulted in a significantly improved locomotion of SCI animals through ameliorating neuroinflammation, reducing apoptosis, and inducing neuronal regrowth by facilitating a desirable microenvironment.Keywords
This publication has 92 references indexed in Scilit:
- Exosomes Derived from Mesenchymal Stem CellsInternational Journal of Molecular Sciences, 2014
- Risk factors in the development of stem cell therapyJournal of Translational Medicine, 2011
- Altered microRNA expression following traumatic spinal cord injuryExperimental Neurology, 2009
- Heterogeneity of Multipotent Mesenchymal Stromal Cells: From Stromal Cells to Stem Cells and Vice VersaTransplantation, 2009
- Proteomic profiling of exosomes: Current perspectivesProteomics, 2008
- Mesenchymal stem cells: A promising candidate in regenerative medicineThe International Journal of Biochemistry & Cell Biology, 2008
- Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantationJournal of Translational Medicine, 2007
- Exosomes are released by cultured cortical neuronesMolecular and Cellular Neuroscience, 2006
- Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrowBlood, 2001
- Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes.Journal of Cell Biology, 1983